Allogene Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALLO and other ETFs, options, and stocks.About ALLO
Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells.
CEODavid D. Chang
CEODavid D. Chang
Employees361
Employees361
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2017
Founded2017
Employees361
Employees361
ALLO Key Statistics
Market cap768.52M
Market cap768.52M
Price-Earnings ratio-2.13
Price-Earnings ratio-2.13
Dividend yield—
Dividend yield—
Average volume3.22M
Average volume3.22M
High today$4.57
High today$4.57
Low today$4.36
Low today$4.36
Open price$4.41
Open price$4.41
Volume341.68K
Volume341.68K
52 Week high$6.89
52 Week high$6.89
52 Week low$2.23
52 Week low$2.23
Analyst ratings
69%
of 16 ratingsBuy
68.8%
Hold
31.3%
Sell
0%